Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

被引：0
|
作者：
B. L. Langdahl
F. Marin
E. Shane
H. Dobnig
J. R. Zanchetta
M. Maricic
K. Krohn
K. See
M. R. Warner
机构：
[1] Åarhus University Hospital,Lilly Research Laboratories
[2] Åarhus Sygehus,Instituto de Investigaciones Metabólicas, School of Medicine
[3] Eli Lilly and Company,undefined
[4] Columbia University,undefined
[5] Medical University of Graz,undefined
[6] USAL University,undefined
[7] Catalina Pointe Arthritis and Rheumatology Specialists,undefined
来源：
Osteoporosis International | 2009年 / 20卷
关键词：
Alendronate; Bone biomarkers; Glucocorticoid-induced osteoporosis; PINP; Premenopausal; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2095 / 2104
页数：9
相关论文
共 50 条
  • [1] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status
    Langdahl, B. L.
    Marin, F.
    Shane, E.
    Dobnig, H.
    Zanchetta, J. R.
    Maricic, M.
    Krohn, K.
    See, K.
    Warner, M. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (12) : 2095 - 2104
  • [2] Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status-24-month results
    Dobnig, H.
    Warner, M. R.
    Langdahl, B. L.
    Moericke, R.
    See, K.
    Marin, F.
    [J]. BONE, 2009, 44 (02) : S235 - S235
  • [3] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Babb, Richard R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1302 - 1303
  • [4] Teriparatide or alendronate in glucocorticoid-induced osteoporosis
    Saag, Kenneth G.
    Shane, Elizabeth
    Boonen, Steven
    Marin, Fernando
    Donley, David W.
    Taylor, Kathleen A.
    Dalsky, Gail P.
    Marcus, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20): : 2028 - 2039
  • [5] TERIPARATIDE VERSUS ALENDRONATE FOR TREATING GLUCOCORTICOID-INDUCED OSTEOPOROSIS: 36-MONTH RESULTS
    Devogelaer, J. -P.
    Warner, M.
    Saag, K.
    Zanchetta, J.
    Adler, R.
    Eastell, R.
    See, K.
    Dalsky, G.
    Krohn, K.
    Krege, J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 7 - 7
  • [6] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Woolf, Anthony D.
    Akesson, Kristina
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (05): : 236 - 237
  • [7] Is teriparatide or alendronate the best treatment for glucocorticoid-induced osteoporosis?
    Anthony D Woolf
    Kristina Åkesson
    [J]. Nature Clinical Practice Rheumatology, 2008, 4 : 236 - 237
  • [8] Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis
    Saag, K. G.
    Shane, E.
    Boonen, S.
    Donley, D. W.
    Marin, F.
    Warner, M. R.
    Taylor, K. A.
    Dalsky, G. R.
    Marcus, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 117 - 117
  • [9] Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis
    Warner, Margaret R.
    Saag, Kenneth G.
    Shane, Elizabeth
    Boonen, Steven
    Donley, David W.
    Marin, Fernando
    Taylor, Kathleen A.
    Dalsky, Gail P.
    Marcus, Robert
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S222 - S222
  • [10] Teriparatide versus Alendronate for Treatment of Glucocorticoid-Induced Osteoporosis: 36-month Results
    Saag, K. G.
    Zanchetta, J. R.
    Devogelaer, J. P.
    Adler, R. A.
    See, K.
    Dalsky, G. P.
    Krohn, K.
    Krege, J. H.
    Warner, M. R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S49 - S49
12345